Net sales rose 56% year-over-year and net loss narrowed, with improved cash flow and expanded credit lines. U.S. and Canadian regulatory processes are ongoing, and new distribution and product initiatives are underway.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.